Differences in specificity of "DPw2-specific" cytotoxic T cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones.
Seven allospecific cytotoxic T lymphocyte (CTL) clones derived from DPw2-specific bulk populations were characterized by three approaches to obtain a more detailed understanding of the T cell recognition of the HLA-DPw2 molecule. All seven of the clones were DPw2 specific and indistinguishable in specificity by three approaches: (a) patterns of lysis of panels of targets from normal donors; (b) inhibition of lysis by anti-class II monoclonal antibodies (mAb); (c) lysis of mutant lymphoblastoid B cell lines (LCL) with isolated loss of DP2 alpha or DP2 beta gene expression (as a result of selection for resistance to DPw2-specific CTL). However, only four of the seven CTL clones (which we designate "orthodox") lysed all mutant DPw2+ LCL tested; the other three ("heterodox") CTL clones showed reduced or no lysis of particular LCL which expressed DPw2 but had been mutagenized and selected for loss of DR expression. Cold target blocking experiments with the mutant LCL confirmed differences in: (a) specificity among CTL clones and (b) CTL-defined phenotype among serologically indistinguishable DR-DPw2+ mutant LCL. Differences were not explained by different levels of DP expression by the mutant LCL. Given the nature of the mutagens and mutations, it is highly improbable that point mutations in DP account for differences in recognition. These data suggest that non-DP HLA genes influence recognition by some DP-specific clones, potentially due to corecognition of HLA-DR alpha or another non-DP HLA product in the context of a DPw2 alpha/beta dimer.
Sánchez Pérez
M
M
Departamento de Microbiología II, Facultad de Farmacia, Universidad Complutense de Madrid, Spain.
Diez Orejas
R
R
Petersen
J W
JW
De Mars
R
R
Shaw
S
S
D000911:Antibodies, Monoclonal / Q000276:immunology; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic; D005796:Genes; D005802:Genes, MHC Class II; D005809:Genes, Regulator; D006682:HLA-DP Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000235:genetics; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D009154:Mutation; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000911:Antibodies, Monoclonal; D006682:HLA-DP Antigens; D006684:HLA-DR Antigens